Environment and Public Health

13 trials 7 recruiting

Filter these 13 trials by phase, country and sponsor.

Open in Search →

EarLy extra Measles immunisation during a measles Outbreak (ELMO) Pending

2024-513395-18-00 Healthy infants receiving a profylactic vaccine to prev 6
IRONGIRLS-PILOT: Feasibility of Alternate-Day Iron Supplementation in Adolescent Girls Pending

2025-522498-12-00 iron deficiency in adolescent girls 6
A Phase 1 Study of Fentanyl Vaccine Recruiting

2025-524277-16-00 Opioid induced respiratory depression 7 2026-02-26
Continuing ovulation induction with letrozole versus switching to gonadotropins in women with polycystic ovary syndrome (MOVIN-II study) Recruiting

2024-519354-36-00 Polycystic ovary syndrome (PCOS) 6 2025-08-01
Semaglutide 2.4mg for low responders after bariatric surgery Recruiting

2022-502164-20-01 obesity 6 2025-03-11
Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A Recruiting

2023-507348-35-00 Risk for Type 1 Diabetes 6 2024-05-30
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for SC use) versus plac… Recruiting

2022-502046-28-00 HER2-Positive, PIK3CA Mutated, Locally Advanced or Meta 5 2023-12-22
A Study to Compare the Efficacy and Safety of Glofitamab as a Single Agent Versus Investigator’s Choice in Patients with Relapsed/Refractory… Recruiting

2023-503206-37-00 Mantle Cell Lymphoma (MCL) 5 2023-11-20
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Che… Recruiting

2023-504264-41-00 CD20 positive B-Cell Non-Hodgkin Lymphoma (NHL) 9 2022-11-04
A Study of Susceptibility to Baloxavir Marboxil in Patients with Influenza and its transmission to their household contacts Ended

2023-504672-22-00 Influenza 5 2023-11-24
A study of lurbinectedin in combination with atezolizumab compared with atezolizumab as maintenance therapy in participants with extensive-s… Ended

2023-503868-16-00 Small-Cell Lung Cancer (SCLC) 5 2022-02-14
This study will evaluate the safety, tolerability, and pharmacokinetics of Runimotamab administered intravenously as a single agent and in c… Ended

2023-504491-15-00 Human epidermal growth factor receptor (HER2)-Expressin 1 2020-10-30
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Clinical Activity of RO7276389 Alone and in Combination with Cobimetinib in Pa… Ended

2023-506310-43-00 BRAF-V600 Mutation-Positive Advanced Solid Tumor or BRA 1 2022-02-15